See what happens when our team of scientists and marketing experts partner with innovative thinkers and doers. Together, we’re moving consumer healthcare forward.
In the US, some 50 million people suffer from serious nasal allergies, and an estimated 70% of them treat their symptoms with prescription or OTC treatments. However, half of these sufferers report they are not completely satisfied with their current method of prescription treatment. We want to do what we can to make it easier for patients and consumers to access a proven treatment that works for them.
MassChallenge Final
June 25, 2019 Boston
You are now leaving the GlaxoSmithKline Inc. website.
Although GlaxoSmithKline Inc. offers, as a convenience, links to a number of websites that we believe may offer useful information to our visitors ("Linked Sites"), GlaxoSmithKline Inc. makes no warranty of any kind regarding the accuracy and use of the information on these Linked Sites and is not liable for damages of any kind arising out of your access to, or use of, these Linked Sites. The privacy policies, legal information and procedures described on the GlaxoSmithKline Inc. website do not apply to Linked Sites. You must contact these Linked Sites directly for information on their data collection and distribution policies. Your use of and browsing in Linked Sites are at your own risk.
Would you like to continue?